Andere Sprachen Thermo Fisher Scientific Inc.

Aktien

857209

US8835561023

TMO

Medizinische Ausrüstung

Markt geschlossen - Nyse Andere Börsenplätze 22:00:02 09.12.2024			% 5 Tage	% 1. Jan.
537,23 ^USD	+1,49 %		+1,37 %	+1,21 %

09.12.	THERMO FISHER SCIENTIFIC INC. : Bewertung von RBC Capital Markets zum Kaufen erhalten	ZM
04.12.	Thermo Fisher Scientific Insider verkaufte Aktien im Wert von $10.624.559, laut einer aktuellen SEC Einreichung	MT

Andere Sprachen

Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!

100% kostenlose Registrierung

Thermo Fisher Scientific Launches CTS Detachable Dynabeads CD4 and CTS Detachable Dynabeads CD8 to Enhance Cell Therapy Development and Production	05.12.
Thermo Fisher Scientific Insider Sold Shares Worth $10,624,559, According to a Recent SEC Filing	04.12.
Thermo Fisher Scientific Launches CTS? Detachable Dynabeads? CD4 and CTS Detachable Dynabeads CD8 to Enhance Cell Therapy Development and Production	04.12.
Thermo Fisher Scientific Completes $1B Share Repurchase	04.12.
Thermo Fisher Scientific Authorizes $4 Billion of Share Repurchases	18.11.
"Cinco acciones a comprar tras la victoria de Donald Trump en Estados Unidos"	16.11.
Thermo Fisher Scientific Authorizes $4 Billion Share Buyback	15.11.
Thermo Fisher Board Approves New $4 Billion Stock Buyback	15.11.
Thermo Fisher Scientific Authorizes $4 Billion of Share Repurchases	15.11.
Tranche Update on Thermo Fisher Scientific Inc.'s Equity Buyback Plan announced on November 14, 2023.	15.11.
Thermo Fisher Scientific Inc. announces an Equity Buyback for $4,000 million worth of its shares.	15.11.
Thermo Fisher Scientific Inc.'s Equity Buyback announced on November 14, 2023, has expired with 5,523,139 shares, representing 1.43% for $3,000 million.	15.11.
Thermo Fisher Scientific Inc. authorizes a Buyback Plan.	15.11.
OncoHost Announces Executive Appointment of Ron Andrews	14.11.
Mainz Biomed, Thermo Fisher Partner to Develop Colorectal Cancer Screening Test	12.11.
Mainz Biomed and Thermo Fisher Scientific Sign a Collaboration Agreement for the Development of Next Generation Colorectal Cancer Screening Product for Global Markets	12.11.
Mainz Biomed N.V. and Thermo Fisher Scientific Inc. Sign a Collaboration Agreement for the Development of Next Generation Colorectal Cancer Screening Product for Global Markets	12.11.
Thermo Fisher Scientific to Present at the Wolfe 2024 Healthcare Conference on November 19, 2024	11.11.
Quidelortho Corporation Announces Executive Changes	08.11.
Thermo Fisher Scientific Keeps Quarterly Dividend at $0.39/Share, Payable Jan. 15 to Holders on Dec. 13	07.11.
Thermo Fisher Scientific Declares Quarterly Dividend	07.11.
Thermo Fisher Scientific Inc. Declares Quarterly Cash Dividend, Payable on January 15, 2025	07.11.
Seer Enters into A Co-Marketing and Sales Agreement with Thermo Fisher Scientific	06.11.
Tranche Update on Thermo Fisher Scientific Inc.'s Equity Buyback Plan announced on November 14, 2023.	01.11.
Thermo Fisher Scientific Insider Sold Shares Worth $11,049,123, According to a Recent SEC Filing	30.10.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Schlagzeilen

Thermo Fisher: Besser geht's kaum

Am 26. Juli 2024 um 11:44 Uhr